A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
PURPOSE: Sodium oxybate (SXB) is approved for cataplexy and excessive daytime sleepiness in narcolepsy. Obstructive sleep apnea syndrome (OSAS) affects ∼9-50% of narcoleptics. Effects of 2-week SXB administration on apnea-hypopnea index (AHI), oxygen saturation (SaO(2)), and sleep architecture were investigated in OSAS patients. METHODS: OSAS patients (n = 48) received 2-week SXB or placebo (PBO) treatment with polysomnography at baseline and day 14. The primary outcome measure was change from baseline in mean AHI. Secondary outcomes included changes from baseline in SaO(2), and sleep architecture. RESULTS: Compared with PBO, SXB significantly increased reduction in mean AHI and obstructive apnea index with SXB (-0.8 ± 13.3 vs. -8.2 ± 10.0; p = 0.0327 and 3.54 ± 11.1 vs. -4.72 ± 7.7; p = 0.0054, respectively) and significantly increased change in slow wave sleep duration (5.2 ± 25.0 min vs. 29.4 ± 37.0 min; p = 0.0038). There were no differences between treatments in SaO2, central apneic events, or other measures. Adverse events, most commonly headache, were noted in nine of 27 (33%) and six of 23 (26%) patients receiving SXB and PBO, respectively. CONCLUSIONS: Short-term use of 4.5 g/night SXB did not generate respiratory depressant effects in OSAS patients as measured by AHI, obstructive apnea events, central apneas, and SaO2. Extended use of SXB in higher therapeutic doses in OSAS has not been studied, and merits caution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Though current data is mixed regarding this possibility,992–995”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [992]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale
Johns, M. W. (1991) · Sleep · doi:10.1093/sleep/14.6.540 · Cited by 17,364 · cited 1×
“Secondary outcomes included the mean changes in sleep architecture, oxygenation variables and Epworth Sleepiness Scale (ESS) scores [22].”
MethodRechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 12,637
The Occurrence of Sleep-Disordered Breathing among Middle-Aged Adults
Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., & Badr, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304293281704 · Cited by 10,183 · cited 1×
“SXB is currently a standard treatment for narcolepsy, where a potentially large proportion (9–50%) of patients may also have diagnosed or undetected OSAS [13, 15, 16].”
BackgroundAllan Hobson, J. (1969) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(69)90021-2 · Cited by 5,192
Principles and Practice of Sleep Medicine
(2011) · Elsevier eBooks · doi:10.1016/c2009-0-59875-3 · Cited by 5,088
McNicholas, W. T., Strohl, K. P., White, D. P., Levy, P. A., Schmidt, W., Wheatley, J. R., Redline, S. S., Carley, D. W., Buysse, D. J., Young, T. B., et al. (1999) · PubMed · Cited by 3,665
The Triad of Sleep Apnea, Hypertension, and Chronic Kidney Disease: A Spectrum of Common Pathology
Aziz, F., & Chaudhary, K. (2017) · Cardiorenal Medicine · doi:10.1159/000450796 · Cited by 3,267
Longitudinal Study of Moderate Weight Change and Sleep-Disordered Breathing
Peppard, P. E. (2000) · JAMA · doi:10.1001/jama.284.23.3015 · Cited by 2,020
Obesity and Obstructive Sleep Apnea: Pathogenic Mechanisms and Therapeutic Approaches
Schwartz, A. R., Patil, S. P., Laffan, A. M., Polotsky, V., Schneider, H., & Smith, P. L. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200708-137mg · Cited by 730 · cited 1×
“The incidence of OSAS in narcolepsy may be related to an association between the high risk of OSAS with obesity [16–18], the higher body-mass-index found in narcoleptics compared with the general population, and binge-eating seen in childhood-onset narcolepsy [19, 20].”
Background
Research works printed but not linked: 3
- Santamaria J, Sansa G, Iranzo A (2007) Prevalence and clinical relevance of sleep apnea in narcolepsy. Sleep 30(Suppl):A224–A225
- Black JE, Ristanovic R, Mamelak M, Montplaisir J (2002) Effect of increasing doses of sodium oxybate on nocturnal oxygen saturation: preliminary findings. Sleep 25(Suppl):A474–A475
- Ristanovic R, Black J, Mamelak M, Montplaisir J (2002) Analysis of dose effects of sodium oxybate on nocturnal respiratory disturbances. Sleep 25(Suppl):A473–A474
Cited by
Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome
Lv, R., Liu, X., Zhang, Y., Dong, N., Wang, X., He, Y., Yue, H., & Yin, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01496-3 · Cited by 477
International Consensus Statement on Obstructive Sleep Apnea
Chang, J. L., Goldberg, A. N., Alt, J. A., Mohammed, A., Ashbrook, L., Auckley, D., Ayappa, I., Bakhtiar, H., Barrera, J. E., Bartley, B. L., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23079 · Cited by 350
Drug therapy for obstructive sleep apnoea in adults
Smith, I., Lasserson, T. J., & Wright, J. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003002.pub2 · Cited by 132
Metadata
- Authors
- George, C. F. P., Feldman, N., Zheng, Y., Steininger, T. L., Grzeschik, S. M., Lai, C., & Inhaber, N.
- Affiliations
- Western University (CA)
- Jazz Pharmaceuticals (United States) (US)
- Corresponding author
- George, Charles F. P.
- Venue
- Sleep and Breathing
- Published
- 2010-01-18
- Volume
- 15
- Issue
- 1
- Pages
- 13-20
- ISSN
- 1520-9512 (ISSN-L)
- 1522-1709
- PMC
- PMC3098358
- OpenAlex
- W2160493529
- Cited by
- 40
- References
- 36
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 5 · 2023: 1 · 2022: 3 · 2021: 2 · 2019: 3 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 3 · 2012: 2
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/2.0 (tdm)
- Locations
- Sleep And Breathing (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Sanofi
- Jazz Pharmaceuticals
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Keywords
- sodium oxybate, obstructive sleep apnea, narcolepsy, apnea-hypopnea index, obstructive apnea, slow-wave sleep, oxygen saturation, central sleep apnea, respiratory depression, drug safety, headache adverse event
- MeSH terms
- Zolpidem, Modafinil, Adult, Central Nervous System Stimulants, Adjuvants, Anesthesia, Benzhydryl Compounds, Combined Modality Therapy, Drug Therapy, Combination, Female, Humans, Disorders of Excessive Somnolence, Hypnotics and Sedatives, Male, Middle Aged, Pyridines, Sodium Oxybate, Polysomnography, Sleep Apnea, Obstructive, Continuous Positive Airway Pressure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome. https://app.cochat.ai/papers/10.1007/s11325-009-0320-0
- The paper
- George, C. F. P., Feldman, N., Zheng, Y., Steininger, T. L., Grzeschik, S. M., Lai, C., & Inhaber, N. (2011). A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome. Sleep and Breathing. https://doi.org/10.1007/s11325-009-0320-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.